Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...
In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use ...
AI tools are proliferating across pulmonary medicine and critical care, with promising early results in diagnostics and ...
Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood ...
Nutritionist Vanesa León reveals how fiber and fresh foods can improve your gut microbiome after 40 and support better health ...
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding use of ...
Realistic fitness goals include running a mile in six weeks or achieving a 5K in 12 weeks. Rest days prevent burnout and ...
An analysis of the Bucharest Early Intervention Project data found that children who were randomly assigned to foster care ...
We would like to believe that every new father and every new mother wants the same thing: a way to protect their child’s ...
Morning Overview on MSN
GLP-1 weight-loss drugs may slow cancer’s spread, a 10,000-patient study found
A study tracking more than 10,000 patients with early-stage, obesity-related cancers found that those taking GLP-1 receptor ...
News you should know, including an idea to decrease the effects of El Nino; the U.S. wants other nations to help fight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results